We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lunglife Ai Inc | LSE:LLAI | London | Ordinary Share | ORD USD0.0001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -6.67% | 28.00 | 29.00 | 31.00 | 30.00 | 30.00 | 30.00 | 10,000 | 16:35:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLLAI
RNS Number : 6835V
LungLife AI, INC
06 April 2023
LungLife AI, Inc.
(the "Company" or "LungLife")
Publication of Annual Report and Accounts & Notice of AGM
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that the Annual Report and Accounts, Notice of Annual General Meeting ("AGM"), Form of Direction and associated Form of Proxy are now available on the Company's website and have been posted to those shareholders who have opted out of electronic communications .
The documents are available here: https://investors.lunglifeai.com/
The Company's AGM will be held at 3:00 P.M. (BST) on 4 May 2023, at Investec Bank plc, 30 Gresham Street, London, EC2V 7QP. The Board will make arrangements for shareholders to listen to proceedings remotely should they wish to do so. The Company will announce details of how to listen to the meeting remotely and any other significant changes to the meeting arrangements via RNS and on LungLife's website at https://investors.lunglifeai.com/
Shareholders are strongly encouraged to vote by proxy, whether or not they plan to attend the Company's AGM in person. Shareholders may register their votes on the resolutions of the AGM by completing and returning the Form of Proxy that accompanies the Notice of AGM in accordance with the instructions printed on the Form of Proxy.
Where shareholders hold Common Shares by way of dematerialised depository interests representing underlying Common Shares ("Depository Interests"), they can vote through the CREST system or by returning a Form of Direction to the Company's agent, Link Group. Further instructions are set out in the Notes to the Notice of AGM.
The resolutions to be proposed at the AGM are summarised in the Notice of AGM.
The results of voting on the resolutions will be announced via a regulatory information service and posted on the Company's website as soon as practicable possible after the AGM.
For further information please contact:
LungLife AI, Inc. www.lunglifeai.com Paul Pagano, CEO Via Walbrook PR David Anderson, CFO Investec Bank plc (Nominated Adviser Tel: +44 (0)20 7597 5970 & J oint Broker) Virginia Bull / Cameron MacRitchie / Lydia Zychowska Goodbody (Joint Broker) Tel: +44 (0) 20 3841 6202 / +353 (1) Tom Nicholson / Stephen Kane 667 0420 Walbrook PR Limited Tel: +44 (0)20 7933 8780 or LungLifeAI@walbrookpr.com Stephanie Cuthbert / Alice Woodings Mob: 07980 541 893 / 07407 804 654 / / Phillip Marriage 07867 984 082
About LungLife
LungLife AI is a developer of clinical diagnostic solutions designed to make a significant impact in the early detection of lung cancer, the deadliest cancer globally. Using a minimally invasive blood draw, the Company's LungLB(R) test is designed to deliver additional information to clinicians who are evaluating indeterminate lung nodules. For more information visit www.lunglifeai.com
Our Purpose is to be a driving force in the early detection to lung cancer. Our Vision is to invert the 20:80 ratio such that in years to come at least 80% of lung cancer is detected early.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOAIFMITMTIMBPJ
(END) Dow Jones Newswires
April 06, 2023 10:50 ET (14:50 GMT)
1 Year Lunglife Ai Chart |
1 Month Lunglife Ai Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions